Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study

Figure 1

Quarterly percentages of the study population receiving ESA alone and ESA + IV iron from 2006–2008.